An investor briefing with three ASX‑listed platforms embedded in healthcare, clinical research and adviser‑led wealth management, where reliability, compliance and trust decide who gets to own the AI layer.
Cogstate, Alcidion and Netwealth each run mission‑critical platforms at the intersection of trusted data, complex regulation and high‑stakes customer relationships: CNS drug development, hospitals and health systems, and adviser‑led wealth management. In these environments, deeply embedded technology that orchestrates information, workflows, decisions and compliance creates a structural defence against both new entrants and generic AI tools.
Timed for investors reassessing where durable AI value will accrue beyond global mega‑cap technology names, this session is an on‑the‑ground look at three ASX‑listed platforms that already sit inside the workflow, control high‑quality governed data, and can apply intelligence with human oversight.
In a market increasingly distinguishing between companies merely exposed to AI and those with the data, workflow depth, distribution and governance to apply it responsibly, these three offer exposure to highly regulated, intelligent infrastructure in critical markets, with enduring customer relationships, high switching costs and recurring‑like revenue.
Hover to learn more
Standardised cognition as a data moat: validated digital cognitive assessments, deep CNS trial expertise and longitudinal datasets embedded in global drug‑development workflows, where sponsors need instruments and data regulators will accept.
Learn more →
Hover to learn more
AI‑ready clinical infrastructure: the Miya Precision platform is modular and interoperable, sitting across existing hospital systems to consolidate information, support clinical decisions and build the governed data foundation responsible AI requires.
Learn more →
Hover to learn more
The intelligence layer for advice: connected data, connected workflows and a Single Advice Desktop built for a regulated, trust‑dependent industry, with AI applied internally first: proof before promotion, human accountability at the centre.
Learn more →Hear directly from leadership at Cogstate, Alcidion and Netwealth on how clinical trials, hospitals and adviser‑led wealth management actually run, and where technology sits inside them.
See where AI is already in production rather than on a roadmap, and how these teams think about security, data sovereignty, privacy, governance and human accountability.
Platform change in these markets carries operational, data‑migration, client‑service and compliance risk. Understand what that depth of integration means for revenue durability and pricing power.
Put your questions to senior executives alongside analysts and commentators from Bell Potter, Canaccord Genuity and Armchair Analyst, then keep the conversation going over networking.
This briefing is designed for investors and advisers reassessing where durable AI value will accrue beyond global mega-cap technology names.
On Thursday 13 August 2026, the inaugural ASX Investor Event ran at the Murdoch Center on 3rd Avenue in New York. Hansen Technologies, Cogstate and Alcidion each gave a 10‑minute overview of their business before joining a panel discussion and audience Q&A on where AI value accrues in regulated, mission‑critical markets.
Short, substantive company presentations, a candid panel with specialist analysts, and time afterwards for investors to speak with management directly. That event was supported by the American Australian Association and Alleato. Melbourne follows the same structure, with an Australian audience and an Australian line‑up.
Download the event booklet PDF, opens in a new tab
Places are limited and allocated in order of registration. Complete the form and we will confirm your place by email, along with venue and arrival details.
Thank you. We have your registration for the Melbourne ASX Investor Event on Thursday 29 October 2026. A confirmation email with venue and arrival details is on its way.
Listed companies deserve better tools to engage investors, that's why we built InvestorHub.
InvestorHub's software is designed for listed company executives, investor relations teams and advisors. We bring investor engagement, content distribution and shareholder analytics together in one platform, giving teams a clearer picture of who their investors are and how to reach them.
InvestorHub replaces disconnected tools with a single solution built to fit inside existing workflows from day one.
More than 295 ASX, LSE, AIM and AQSE listed companies use InvestorHub to scale direct investor relationships beyond their top 20 shareholders without adding workload. The result: more investor demand captured, and better on-market outcomes.
